Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Value of Early Response to Tegoprazan in GERD
NCT07826455Phase 4Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Sep 2026
- Primary completion
- Jul 2028
01
Overview
A Phase 4 trial of tegoprazan in gastroesophageal reflux disease (GERD), sponsored by HK inno.N Corporation. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tegoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT07826455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826455.